EFG Asset Management (Americas)’s NYLIM Hedge Multi-Strategy Tracker ETF QAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-16,928
Closed -$494K 143
2023
Q1
$494K Sell
16,928
-16,928
-50% -$491K 0.12% 103
2022
Q4
$964K Hold
33,856
0.24% 95
2022
Q3
$939K Hold
33,856
0.24% 92
2022
Q2
$971K Buy
33,856
+1,691
+5% +$50K 0.23% 92
2022
Q1
$992K Hold
32,165
0.18% 90
2021
Q4
$1.02M Hold
32,165
0.17% 92
2021
Q3
$1.02M Hold
32,165
0.18% 92
2021
Q2
$1.04M Hold
32,165
0.19% 94
2021
Q1
$1.02M Hold
32,165
0.21% 93
2020
Q4
$1.03M Hold
32,165
0.21% 94
2020
Q3
$997K Hold
32,165
0.22% 91
2020
Q2
$975K Buy
32,165
+6,342
+25% +$188K 0.25% 90
2020
Q1
$735K Buy
+25,823
New +$776K 0.24% 92
2015
Q3
Sell
-7,412
Closed -$222K 98
2015
Q2
$222K Sell
7,412
-293
-4% -$8.78K 0.14% 92
2015
Q1
$231K Buy
+7,705
New +$229K 0.18% 67

Other funds holding QAI

EFG Asset Management (Americas)'s QAI Position: Q2 2023 in Review

EFG Asset Management (Americas) sold out of NYLIM Hedge Multi-Strategy Tracker ETF (QAI) in Q2 2023, closing a stake of 16,928 shares — an estimated $494K sold.

EFG Asset Management (Americas) first reported a position in QAI in Q1 2015 and held it in 15 quarters. The position peaked at $1.04M in Q2 2021. 104 funds tracked by Wall St. Rank hold QAI as of Q2 2023.

  • EFG Asset Management (Americas) reported no remaining NYLIM Hedge Multi-Strategy Tracker ETF position as of Q2 2023 after selling out during the quarter.
  • EFG Asset Management (Americas) sold 16,928 NYLIM Hedge Multi-Strategy Tracker ETF shares in Q2 2023, an estimated $494K.
  • EFG Asset Management (Americas) first reported a position in NYLIM Hedge Multi-Strategy Tracker ETF in Q1 2015 and held it in 15 quarters.
  • EFG Asset Management (Americas)'s NYLIM Hedge Multi-Strategy Tracker ETF position peaked at $1.04M in Q2 2021.
  • 104 funds tracked by Wall St. Rank held NYLIM Hedge Multi-Strategy Tracker ETF as of Q2 2023.

Based on EFG Asset Management (Americas)'s 13F filing for Q2 2023, filed 29 Aug 2023.